PubMed · 520097
Chronochemotherapy: L 1210 leukemia and beyond.
Abstract
In cancer and other therapeutic research, an interpretation of median survival times can and should take cure into account. With this qualification, an analysis of recently published data provides further statistically significant evidence in favor of cancer chronotherapy as compared to homeostatic therapy.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
F Halberg, W Nelson, G Cornélissen, E Haus, L E Scheving, R A Good. Chronochemotherapy: L 1210 leukemia and beyond.. https://pubmed.ncbi.nlm.nih.gov/520097/
Cite the original work for its findings. Save a collection to share your selection of sources.